Clinics in Dermatology
Volume 26, Issue 2 , Pages 106-122 , March 2008

Hyaluronan in skin: aspects of aging and its pharmacologic modulation

  • Robert Stern, MD

      Affiliations

    • Department of Pathology, School of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
    • Corresponding Author InformationCorresponding author. Department of Pathology and University of California San Francisco Comprehensive Cancer Center, School of Medicine, University of California San Francisco, San Francisco, CA 94143-0506, USA. Tel.: +1 415 476 4961, +1 415 577 1735 (cell); fax: +1 415 476 3867.
    • ,
  • Howard I. Maibach, MD

      Affiliations

    • Department of Dermatology, School of Medicine, University of California San Francisco, San Francisco, CA 94143, USA

References 

  1. Vom Knorbelgewebe Henle F. In: Allgemeine Anatomielehre, von dem Mischungs und Formbestandteilen des menschlichen Koerpers. Leipzig: Leopold Voss Verlag; 1841;p. 791–805
  2. Koelliker A, Von den Geweben R. In: Handbuch der Gewebelehre des Menschen. Leipzig: Wilhelm Engelmann Verlag; 1852;p. 51
  3. Duran-Reynals F. Exaltation de l'activité du virus vaccinal par les extraits de certains organs. CR Soc Biol. 1928;99:6–7
  4. Duran-Reynals F, Suner Pi J. Exaltation de l'activité du Staphylocoque par les extraits testiculaires. CR Soc Biol. 1929;99:1908–1911
  5. Duran-Reynals F. The effect of extracts of certain organs from normal and immunized animals on the infecting power of virus vaccine virus. J Exp Med. 1929;50:327–440
  6. Duran-Reynals F, Stewart FW. The action of tumor extracts on the spread of experimental vaccinia of the rabbit. Am J Cancer. 1933;15:2790–2797
  7. Duran-Reynals F. Studies on a certain spreading factor existing in bacteria and its significance for bacterial invasiveness. J Exp Med. 1933;58:161–181
  8. Chain E, Duthie ES. Identity of hyaluronidase and spreading factor. Br J Exp Pathol. 1940;21:324–338
  9. Hobby GL, Dawson MH, Meyer K, et al. The relationship between spreading factor and hyaluronidase. J Exp Med. 1941;73:109–123
  10. Casals J. Significance and transcendence of the scientific work of Duran-Reynals. Viruses and cancer. Span Biochem Soc Press. 1971;416
  11. Meyer K. The chemistry and biology of mucopolysaccharides and glycoproteins. Sympos Quant Biol. 1938;6:91–105
  12. Meyer K, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem. 1934;107:629–634
  13. Rapport MM, Weissman B, Linker A, et al. Isolation of a crystalline disaccharide, hyalobiuronic acid, from hyaluronic acid. Nature. 1951;168:996–998
  14. Reed RK, Lilja K, Laurent TC. Hyaluronan in the rat with special reference to the skin. Acta Physiol Scand. 1988;134:405–411
  15. Toole BP. Proteoglycans and hyaluronan in morphogenesis and differentiation. In: Hay E  editors. Cell biology of extracellular matrix. New York: Plenum Press; 1991;p. 305–341
  16. Fraser JR, Laurent TC, Pertoft H, et al. Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J. 1981;200:415–424
  17. Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol. 1986;119:219–234
  18. DePalma RL, Krummel TM, Durham LA, et al. Characterization and quantitation of wound matrix in the fetal rabbit. Matrix. 1989;9:224–231
  19. Mast BA, Flood LC, Haynes JH, et al. Hyaluronic acid is a major component of the matrix of fetal rabbit skin and wounds: implications for healing by regeneration. Matrix. 1991;11:63–68
  20. Longaker MT, Chiu ES, Adzick NS, et al. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg. 1991;213:292–296
  21. Knudson W. Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion. Am J Pathol. 1996;148:1721–1726
  22. Zhang L, Underhill CB, Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 1995;55:428–433
  23. West DC, Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res. 1989;183:179–196
  24. Rooney P, Kumar S, Ponting J, et al. The role of hyaluronan in tumour neovascularization. Int J Cancer. 1995;60:632–636
  25. Horton MR, McKee CM, Bao C, et al. Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem. 1998;273:35088–35094
  26. Horton MR, Burdick MD, Strieter RM, et al. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. J Immunol. 1998;160:3023–3030
  27. Slevin M, Krupinski J, Kumar S, et al. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest. 1998;78:987–1003
  28. Underhill C. CD44: the hyaluronan receptor. J Cell Sci. 1992;103(Pt 2):293–298
  29. Lesley J, Hyman R. CD44 structure and function. Front Biosci. 1998;3:616–630
  30. Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997;71:241–319
  31. Pilarski LM, Masellis-Smith A, Belch AR, et al. RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?. Leuk Lymphoma. 1994;14:363–374
  32. Hall CL, Turley EA. Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis. J Neurooncol. 1995;26:221–229
  33. Bourguignon LY, Lokeshwar VB, Chen X, et al. Hyaluronic acid–induced lymphocyte signal transduction and HA receptor (GP85/CD44)–cytoskeleton interaction. J Immunol. 1993;151:6634–6644
  34. Entwistle J, Hall CL, Turley EA. HA receptors: regulators of signaling to the cytoskeleton. J Cell Biochem. 1996;61:569–577
  35. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006;85:699–715
  36. Formby B, Stern R. Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells: inhibition by antisense complementary to casein kinase II mRNA. Mol Cell Biochem. 1998;187:23–31
  37. Laurent TC, Fraser JR. Hyaluronan. FASEB J. 1992;6:2397–2404
  38. Laurent TC. In: The chemistry, biology, and medical applications of hyaluronan and its derivatives. London: Portland Press; 1998;p. 621
  39. Toole BP. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol. 1990;2:839–844
  40. Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 1993;7:1233–1241
  41. Zhao M, Yoneda M, Ohashi Y, et al. Evidence for the covalent binding of SHAP, heavy chains of inter–alpha-trypsin inhibitor, to hyaluronan. J Biol Chem. 1995;270:26657–26663
  42. Feinberg RN, Beebe DC. Hyaluronate in vasculogenesis. Science. 1983;220:1177–1179
  43. Scott JE. Secondary structures in hyaluronan solutions: chemical and biological implications. In:  Evered D,  Whelan J editor. The biology of hyaluronan. Chichester: John Wiley & Sons; 1989;p. 6–20
  44. Prehm P. Hyaluronate is synthesized at plasma membranes. Biochem J. 1984;220:597–600
  45. Lin W, Shuster S, Maibach HI, Stern R. Patterns of hyaluronan staining are modified by fixation techniques. J Histochem Cytochem. 1997;45:1157–1163
  46. Fessler JH, Fessler LI. Electron microscopic visualization of the polysaccharide hyaluronic acid. Proc Natl Acad Sci U S A. 1966;56:141–147
  47. Wight TN, Heinegaard DK, Hascall VC. Proteoglycan structure and function. In:  Hay ED editors. Cell biology of the extracellular matrix. New York: Plenum Press; 1991;p. 45
  48. Tomida M, Koyama H, Ono T. Hyaluronate synthetase in cultured mammalian cells producing hyaluronic acid; oscillatory change during the growth and suppression by 5-bromodeoxyuridine. Biochim Biophys Acta. 1974;338:352–358
  49. Mian N. Analysis of cell-growth-phase–related variations in hyaluronate synthase activity of isolated plasma-membrane fractions of cultured human skin fibroblasts. Biochem J. 1986;237:333–342
  50. Brecht M, Mayer U, Schlosser E, et al. Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J. 1986;239:445–450
  51. Kujawa MJ, Pechak DG, Fiszman MY, et al. Hyaluronic acid bonded to cell culture surfaces inhibits the program of myogenesis. Dev Biol. 1986;113:10–16
  52. Kujawa MJ, Tepperman K. Culturing chick muscle cells on glycosaminoglycan substrates: attachment and differentiation. Dev Biol. 1983;99:277–286
  53. Pratt RM, Larsen MA, Johnston MC. Migration of cranial neural crest cells in a cell-free hyaluronate-rich matrix. Dev Biol. 1975;44:298–305
  54. Reed RK, Laurent UB, Fraser JR, et al. Removal rate of [3H]-hyaluronan injected subcutaneously in rabbits. Am J Physiol. 1990;259(part 2):H532–H535
  55. Laurent UB, Dahl LB, Reed RK. Catabolism of hyaluronan in rabbit skin takes place locally, in lymph nodes and liver. Exp Physiol. 1991;76:695–703
  56. Engstrom-Laurent A, Hellstrom S. The role of liver and kidneys in the removal of circulating hyaluronan. An experimental study in the rat. Connect Tissue Res. 1990;24:219–224
  57. Onarheim H, Reed RK, Laurent TC. Elevated hyaluronan blood concentrations in severely burned patients. Scand J Clin Lab Invest. 1991;51:693–697
  58. Onarheim H, Missavage AE, Gunther RA, et al. Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J Surg Res. 1991;50:259–265
  59. Berg S, Brodin B, Hesselvik F, et al. Elevated levels of plasma hyaluronan in septicaemia. Scand J Clin Lab Invest. 1988;48:727–732
  60. Onarheim H, Reed RK, Laurent TC. Increased plasma concentrations of hyaluronan after major thermal injury in the rat. Circ Shock. 1992;37:159–163
  61. Engstrom-Laurent A, Laurent UB, Lilja K, et al. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest. 1985;45:497–504
  62. Chichibu K, Matsuura T, Shichijo S, et al. Assay of serum hyaluronic acid in clinical application. Clin Chim Acta. 1989;181:317–323
  63. Lindqvist U, Laurent TC. Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest. 1992;52:613–621
  64. Yannariello-Brown J, Chapman SH, Ward WF, et al. Circulating hyaluronan levels in the rodent: effects of age and diet. Am J Physiol. 1995;268(Pt 1):C952–C957
  65. Hallgren R, Engstrom-Laurent A, Nisbeth U. Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uremia. Nephron. 1987;46:150–154
  66. Lindqvist U, Engstrom-Laurent A, Laurent U, et al. The diurnal variation of serum hyaluronan in health and disease. Scand J Clin Lab Invest. 1988;48:765–770
  67. Cooper EH, Rathbone BJ. Clinical significance of the immunometric measurements of hyaluronic acid. Ann Clin Biochem. 1990;27(Pt 5):444–451
  68. Smedegard G, Bjork J, Kleinau S, et al. Serum hyaluronate levels reflect disease activity in experimental arthritis models. Agents Actions. 1989;27:356–358
  69. Frebourg T, Lerebours G, Delpech B, et al. Serum hyaluronate in malignant pleural mesothelioma. Cancer. 1987;59:2104–2107
  70. Dahl L, Hopwood JJ, Laurent UB, et al. The concentration of hyaluronate in amniotic fluid. Biochem Med. 1983;30:280–283
  71. Longaker MT, Whitby DJ, Adzick NS, et al. Studies in fetal wound healing, VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg. 1990;25:63–68
  72. Decker M, Chiu ES, Dollbaum C, et al. Hyaluronic acid–stimulating activity in sera from the bovine fetus and from breast cancer patients. Cancer Res. 1989;49:3499–3505
  73. Bernfield MR, Banerjee SD, Cohn RH. Dependence of salivary epithelial morphology and branching morphogenesis upon acid mucopolysaccharide–protein (proteoglycan) at the epithelial surface. J Cell Biol. 1972;52:674–689
  74. Gakunga P, Frost G, Shuster S, et al. Hyaluronan is a prerequisite for ductal branching morphogenesis. Development. 1997;124:3987–3997
  75. Delpech B, Girard N, Bertrand P, et al. Hyaluronan: fundamental principles and applications in cancer. J Intern Med. 1997;242:41–48
  76. Ropponen K, Tammi M, Parkkinen J, et al. Tumor cell–associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res. 1998;58:342–347
  77. Lokeshwar VB, Obek C, Soloway MS, et al. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res. 1997;57:773–777
  78. Lokeshwar VB, Soloway MS, Block NL. Secretion of bladder tumor–derived hyaluronidase activity by invasive bladder tumor cells. Cancer Lett. 1998;131:21–27
  79. Bertrand P, Girard N, Duval C, et al. Increased hyaluronidase levels in breast tumor metastases. Int J Cancer. 1997;73:327–331
  80. Madan AK, Yu K, Dhurandhar N, et al. Association of hyaluronidase and breast adenocarcinoma invasiveness. Oncol Rep. 1999;6:607–609
  81. Engstrooem-Laurent A. Changes in hyaluronan concentration in tissues and body fluids in disease states. In:  Evered D,  Whelan J editor. Biology of hyaluronan. Chichester: John Wiley & Sons; 1989;p. 233–247
  82. Brown WT. Progeria: a human-disease model of accelerated aging. Am J Clin Nutr. 1992;55(6 Suppl):1222S–1224S
  83. Kieras FJ, Brown WT, Houck GE, et al. Elevation of urinary hyaluronic acid in Werner's syndrome and progeria. Biochem Med Metabol Biol. 1986;36:276–282
  84. Laurent TC, Laurent UB, Fraser JR. Serum hyaluronan as a disease marker. Ann Med. 1996;28:241–253
  85. Delmage JM, Powars DR, Jaynes PK, et al. The selective suppression of immunogenicity by hyaluronic acid. Ann Clin Lab Sci. 1986;16:303–310
  86. McBride WH, Bard JB. Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J Exp Med. 1979;149:507–515
  87. Forrester JV, Wilkinson PC. Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci. 1981;48:315–331
  88. Dick SJ, Macchi B, Papazoglou S. Lymphoid cell–glioma cell interaction enhances cell coat production by human gliomas: novel suppressor mechanism. Science. 1983;220:739–742
  89. Manley G, Warren C. Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol. 1987;40:626–630
  90. Wilkinson CR, Bower LM, Warren C. The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta. 1996;256:165–173
  91. Delpech B, Chevallier B, Reinhardt N, et al. Serum hyaluronan (hyaluronic acid) in breast cancer patients. Int J Cancer. 1990;46:388–390
  92. Hasselbalch H, Hovgaard D, Nissen N, et al. Serum hyaluronan is increased in malignant lymphoma. Am J Hematol. 1995;50:231–233
  93. Gross RL, Levin AG, Steel CM, et al. In vitro immunological studies on East African cancer patients. II. Increased sensitivity of blood lymphocytes from untreated Burkitt lymphoma patients to inhibition of spontaneous rosette formation. Int J Cancer. 1975;15:132–138
  94. Gross RL, Latty A, Williams EA, et al. Abnormal spontaneous rosette formation and rosette inhibition in lung carcinoma. N Engl J Med. 1975;292:169–181
  95. Burd DA, Siebert JW, Ehrlich HP, et al. Human skin and post-burn scar hyaluronan: demonstration of the association with collagen and other proteins. Matrix. 1989;9:322–327
  96. Piepkorn M, Pittelkow MR, Cook PW. Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor–related growth factors. J Invest Dermatol. 1998;111:715–721
  97. Locci P, Marinucci L, Lilli C, et al. Transforming growth factor beta 1–hyaluronic acid interaction. Cell Tissue Res. 1995;281:317–324
  98. Goldberg RL, Toole BP. Hyaluronate inhibition of cell proliferation. Arthritis Rheum. 1987;30:769–778
  99. Kumar S, West DC. Psoriasis, angiogenesis and hyaluronic acid. Lab Invest. 1990;62:664–665
  100. Tammi R, Paukkonen K, Wang C, et al. Hyaluronan and CD44 in psoriatic skin. Intense staining for hyaluronan on dermal capillary loops and reduced expression of CD44 and hyaluronan in keratinocyte-leukocyte interfaces. Arch Dermatol Res. 1994;286:21–29
  101. Gustafson S, Wikstrom T, Juhlin L. Histochemical studies of hyaluronan and the hyaluronan receptor ICAM-1 in psoriasis. Int J Tissue React. 1995;17:167–173
  102. Eggli PS, Graber W. Association of hyaluronan with rat vascular endothelial and smooth muscle cells. J Histochem Cytochem. 1995;43:689–697
  103. Evanko SP, Wight TN. Intracellular localization of hyaluronan in proliferating cells. J Histochem Cytochem. 1999;47:1331–1342
  104. Grammatikakis N, Grammatikakis A, Yoneda M, et al. A novel glycosaminoglycan-binding protein is the vertebrate homologue of the cell cycle control protein, Cdc37. J Biol Chem. 1995;270:16198–16205
  105. Deb TB, Datta K. Molecular cloning of human fibroblast hyaluronic acid–binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid–binding protein as P-32 protein, co-purified with splicing factor SF2. J Biol Chem. 1996;271:2206–2212
  106. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A. 1992;89:12160–12164
  107. Weiss JM, Sleeman J, Renkl AC, et al. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol. 1997;137:1137–1147
  108. Weiss JM, Renkl AC, Sleeman J, et al. CD44 variant isoforms are essential for the function of epidermal Langerhans cells and dendritic cells. Cell Adhes Commun. 1998;6:157–160
  109. Seiter S, Schadendorf D, Tilgen W, et al. CD44 variant isoform expression in a variety of skin-associated autoimmune diseases. Clin Immunol Immunopathol. 1998;89:79–93
  110. Turley EA. Hyaluronan and cell locomotion. Cancer Metastasis Rev. 1992;11:21–30
  111. Turley E, Harrison R. RHAMM, a member of the hyaladherins. http://www.glycoforum.gr.jp1999;
  112. Mohapatra S, Yang X, Wright JA, et al. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. J Exp Med. 1996;183:1663–1668
  113. Samuel SK, Hurta RA, Spearman MA, et al. TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol. 1993;123:749–758
  114. Hofmann M, Assmann V, Fieber C, et al. Problems with RHAMM: a new link between surface adhesion and oncogenesis?. Cell. 1998;95:591–592
  115. Ripellino JA, Bailo M, Margolis RU, et al. Light and electron microscopic studies on the localization of hyaluronic acid in developing rat cerebellum. J Cell Biol. 1988;106:845–855
  116. Meyer LJ, Stern R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol. 1994;102:385–389
  117. Tammi R, Ripellino JA, Margolis RU, et al. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J Invest Dermatol. 1988;90:412–414
  118. Wang C, Tammi M, Tammi R. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry. 1992;98:105–112
  119. Bertheim U, Hellstrom S. The distribution of hyaluronan in human skin and mature, hypertrophic and keloid scars. Br J Plast Surg. 1994;47:483–489
  120. Tammi R, Tammi M. Hyaluronan in the epidermis. http://www.glycoforum.gr.jp1998;
  121. Tammi R, Saamanen AM, Maibach HI, et al. Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. J Invest Dermatol. 1991;97:126–130
  122. Lamberg SI, Yuspa SH, Hascall VC. Synthesis of hyaluronic acid is decreased and synthesis of proteoglycans is increased when cultured mouse epidermal cells differentiate. J Invest Dermatol. 1986;86:659–667
  123. Frost GI, Stern R. A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal Biochem. 1997;251:263–269
  124. Schachtschabel DO, Wever J. Age-related decline in the synthesis of glycosaminoglycans by cultured human fibroblasts (WI-38). Mech Ageing Dev. 1978;8:257–264
  125. Sluke G, Schachtschabel DO, Wever J. Age-related changes in the distribution pattern of glycosaminoglycans synthesized by cultured human diploid fibroblasts (WI-38). Mech Ageing Dev. 1981;16:19–27
  126. Breen M, Weinstein HG, Blacik LJ, et al. Microanalysis and characterization of glycosaminoglycans from human tissue via zone electrophoresis. In:  Whistler RL,  BeMiller JN editor. Methods in carbohydrate chemistry. New York: Academic Press; 1976;p. 101
  127. Poulsen JH, Cramers MK. Determination of hyaluronic acid, dermatan sulphate, heparan sulphate and chondroitin 4/6 sulphate in human dermis, and a material of reference. Scand J Clin Lab Invest. 1982;42:545–549
  128. Longas MO, Russell CS, He XY. Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr Res. 1987;159:127–136
  129. Gilchrest BA. A review of skin ageing and its medical therapy. Br J Dermatol. 1996;135:867–875
  130. Bernstein EF, Underhill CB, Hahn PJ, et al. Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans. Br J Dermatol. 1996;135:255–262
  131. Prestwich GD, Marecak DM, Marecek JF, et al. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J Control Release. 1998;53:93–103
  132. Vercruysse KP, Prestwich GD. Hyaluronate derivatives in drug delivery. Crit Rev Ther Drug Carrier Syst. 1998;15:513–555
  133. Duranti F, Salti G, Bovani B, et al. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg. 1998;24:1317–1325
  134. Itano N, Kimata K. Molecular cloning of human hyaluronan synthase. Biochem Biophys Res Commun. 1996;222:816–820
  135. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem. 1997;272:13997–14000
  136. Asplund T, Brinck J, Suzuki M, et al. Characterization of hyaluronan synthase from a human glioma cell line. Biochim Biophys Acta. 1998;1380:377–388
  137. Kreil G. Hyaluronidases—a group of neglected enzymes. Protein Sci. 1995;4:1666–1669
  138. Csoka AB, Frost GI, Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001;20:499–508
  139. Csoka TB, Frost GI, Stern R. Hyaluronidases in tissue invasion. Invasion Metastasis. 1997;17:297–311
  140. Guntenhoner MW, Pogrel MA, Stern R. A substrate-gel assay for hyaluronidase activity. Matrix. 1992;12:388–396
  141. Csoka AB, Scherer SW, Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics. 1999;60:356–361
  142. Lapcik L, Chabrecek P, Stasko A. Photodegradation of hyaluronic acid: EPR and size exclusion chromatography study. Biopolymers. 1991;31:1429–1435
  143. Haas E. On the mechanism of invasion. I. Antivasin I, an enzyme in plasma. J Biol Chem. 1946;163:63–68
  144. Dorfman A, Ott ML, Whitney R. The hyaluronidase inhibitor of human blood. J Biol Chem. 1948;223:621–629
  145. Fiszer-Szfarz B. Demonstration of a new hyaluronidase inhibitor in serum of cancer patients. Proc Soc Exp Biol Med. 1968;128:300–302
  146. Kolarova M. Host-tumor relationship XXXIII. Inhibitor of hyaluronidase in blood serum of cancer patients. Neoplasma. 1975;22:435–439
  147. Snively GG, Glick D. Mucolytic enzyme systems. X. Serum hyaluronidase inhibitor in liver disease. J Clin Invest. 1950;29:1087–1090
  148. Grais ML, Glick D. Mucolytic enzyme systems. X. Serum hyaluronidase inhibitor in liver disease. J Clin Inv. 1950;29:1087–1092
  149. Moore DH, Harris TN. Occurrence of hyaluronidase inhibitors in fractions of electrophoretically separated serum. J Biol Chem. 1948;179:377–383
  150. Newman JK, Berenson GS, Mathews MB, et al. The isolation of the non-specific hyaluronidase inhibitor of human blood. J Biol Chem. 1955;217:31–41
  151. Mathews MB, Moses FE, Hart W, et al. Effect of metals on the hyaluronidase inhibitor of human serum. Arch Biochem. 1952;35:93–100
  152. Mathews MB, Dorfman A. Inhibition of hyaluronidase. Physiol Rev. 1955;35:381–402
  153. Kuppusamy UR, Khoo HE, Das NP. Structure-activity studies of flavonoids as inhibitors of hyaluronidase. Biochem Pharmacol. 1990;40:397–401
  154. Kuppusamy UR, Das NP. Inhibitory effects of flavonoids on several venom hyaluronidases. Experientia. 1991;47:1196–1200
  155. Li MW, Yudin AI, VandeVoort CA, et al. Inhibition of monkey sperm hyaluronidase activity and heterologous cumulus penetration by flavonoids. Biol Reprod. 1997;56:1383–1389
  156. Perreault S, Zaneveld LJ, Rogers BJ. Inhibition of fertilization in the hamster by sodium aurothiomalate, a hyaluronidase inhibitor. J Reprod Fertil. 1980;60:461–467
  157. Kakegawa H, Matsumoto H, Satoh T. Inhibitory effects of hydrangenol derivatives on the activation of hyaluronidase and their antiallergic activities. Planta Med. 1988;54:385–389
  158. Kakegawa H, Matsumoto H, Endo K, et al. Inhibitory effects of tannins on hyaluronidase activation and on the degranulation from rat mesentery mast cells. Chem Pharm Bull (Tokyo). 1985;33:5079–5082
  159. Kakegawa H, Mitsuo N, Matsumoto H, et al. Hyaluronidase-inhibitory and anti-allergic activities of the photo-irradiated products of tranilast. Chem Pharm Bull (Tokyo). 1985;33:3738–3744
  160. Tonnesen HH. Studies of curcumin and curcuminoids. XIV. Effect of circumin on hyaluronic acid degradation in vitro. Int J Pharm. 1989;50:91–94
  161. Furuya T, Yamagata S, Shimoyama Y, et al. Biochemical characterization of glycyrrhizin as an effective inhibitor for hyaluronidases from bovine testis. Biol Pharm Bull. 1997;20:973–977
  162. Wolf RA, Glogar D, Chaung LY, et al. Heparin inhibits bovine testicular hyaluronidase activity in myocardium of dogs with coronary artery occlusion. Am J Cardiol. 1984;53:941–944
  163. Szary A, Kowalczyk-Bronisz SH, Gieldanowski J. Indomethacin as inhibitor of hyaluronidase. Arch Immunol Ther Exp (Warsz). 1975;23:131–134
  164. Kushwah A, Amma MK, Sareen KN. Effect of some anti-inflammatory agents on lysosomal and testicular hyaluronidases. Indian J Exp Biol. 1978;16:222–224
  165. Guerra F. Hyaluronidase inhibition by sodium salicylate in rheumatic fever. Science. 1946;103:686–687
  166. Foschi D, Castoldi L, Radaelli E, et al. Hyaluronic acid prevents oxygen free-radical damage to granulation tissue: a study in rats. Int J Tissue React. 1990;12:333–339
  167. Takahashi Y, Ishikawa O, Okada K, et al. Disaccharide analysis of human skin glycosaminoglycans in sun-exposed and sun-protected skin of aged people. J Dermatol Sci. 1996;11:129–133
  168. Uchiyama H, Dobashi Y, Ohkouchi K, et al. Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid. J Biol Chem. 1990;265:7753–7759
  169. Saari H, Konttinen YT, Nordstrom D. Effect of joint mobilization on serum hyaluronate. Ann Med. 1991;23:29–32
  170. Greenwald RA, Moy WW. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum. 1980;23:455–463
  171. Thiele JJ, Traber MG, Packer L. Depletion of human stratum corneum vitamin E: an early and sensitive in vivo marker of UV induced photo-oxidation. J Invest Dermatol. 1998;110:756–761
  172. Kagan V, Witt E, Goldman R, et al. Ultraviolet light-induced generation of vitamin E radicals and their recycling. A possible photosensitizing effect of vitamin E in skin. Free Radic Res Commun. 1992;16:51–64
  173. Fuchs J, Milbradt R. Antioxidant inhibition of skin inflammation induced by reactive oxidants: evaluation of the redox couple dihydrolipoate/lipoate. Skin Pharmacol. 1994;7:278–284
  174. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys. 1993;300:535–543
  175. Kagan V, Serbinova E, Packer L. Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem Biophys Res Commun. 1990;169(29):851–857
  176. Darr D, Dunston S, Faust H, et al. Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants. Acta Derm Venereol. 1996;76:264–268
  177. Kockaert M, Neumann M. Systemic and topical drugs for aging skin. J Drugs Dermatol. 2003;2:435–441
  178. Ditre CM, Griffin TD, Murphy GF, et al. Effects of alpha-hydroxy acids on photoaged skin: a pilot clinical, histologic, and ultrastructural study. J Am Acad Dermatol. 1996;34(Pt 1):187–195
  179. Smith WP. Epidermal and dermal effects of topical lactic acid. J Am Acad Dermatol. 1996;35(Pt 1):388–391
  180. Bernstein EF, Underhill CB, Lakkakorpi J, et al. Citric acid increases viable epidermal thickness and glycosaminoglycan content of sun-damaged skin. Dermatol Surg. 1997;23:689–694
  181. Newman N, Newman A, Moy LS, et al. Clinical improvement of photoaged skin with 50% glycolic acid. A double-blind vehicle-controlled study. Dermatol Surg. 1996;22:455–460
  182. Ash K, Lord J, Zukowski M, McDaniel DH. Comparison of topical therapy for striae alba (20% glycolic acid/0.05% tretinoin versus 20% glycolic acid/10% L-ascorbic acid). Dermatol Surg. 1998;24:849–856
  183. Bergfeld W, Tung R, Vidimos A, et al. Improving the cosmetic appearance of photoaged skin with glycolic acid. J Am Acad Dermatol. 1997;36(Pt 1):1011–1013
  184. Kim SJ, Park JH, Kim DH, et al. Increased in vivo collagen synthesis and in vitro cell proliferative effect of glycolic acid. Dermatol Surg. 1998;24:1054–1058
  185. Wolf BA, Paster A, Levy SB. An alpha hydroxy acid derivative suitable for sensitive skin. Dermatol Surg. 1996;22:469–473
  186. Edward M. Effects of retinoids on glycosaminoglycan synthesis by human skin fibroblasts grown as monolayers and within contracted collagen lattices. Br J Dermatol. 1995;133:223–230
  187. Gilchrest B. Anti-sunshine vitamin A. Nat Med. 1999;5:376–377
  188. Bhawan J. Short- and long-term histologic effects of topical tretinoin on photodamaged skin. Int J Dermatol. 1998;37:286–292
  189. Lundin A, Berne B, Michaelsson G. Topical retinoic acid treatment of photoaged skin: its effects on hyaluronan distribution in epidermis and on hyaluronan and retinoic acid in suction blister fluid. Acta Derm Venereol. 1992;72:423–427
  190. Wang Z, Boudjelal M, Kang S, et al. Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med. 1999;5:418–422
  191. Agren UM, Tammi M, Tammi R. Hydrocortisone regulation of hyaluronan metabolism in human skin organ culture. J Cell Physiol. 1995;164:240–248
  192. Tanaka K, Nakamura T, Takagaki K, et al. Regulation of hyaluronate metabolism by progesterone in cultured fibroblasts from the human uterine cervix. FEBS Lett. 1997;402:223–226

PII: S0738-081X(07)00197-6

doi: 10.1016/j.clindermatol.2007.09.013

Clinics in Dermatology
Volume 26, Issue 2 , Pages 106-122 , March 2008

Article Tools